Mental health screening in Endocrinology

JRCT ID: jRCT1061240021

Registered date:07/06/2024

Basic Information

• Recruitment status: Pending
• Health condition(s) or Problem(s) studied: Endocrine and metabolic disorders. Due to the screening purposes, no direct effects are expected.
• Date of first enrollment: 07/06/2024
• Target sample size: 100
• Study type: Interventional
• Intervention(s): Screening for mental health issues will be conducted among patients. Specifically, the screening will be carried out through electronic devices in the outpatient and inpatient wards of the endocrine and metabolic medicine department, and the results will be sent to the patient's electronic medical record. In the long term, it is expected that the screening results will facilitate communication between doctors and patients, leading to early intervention for psychological issues and a reduction in the rate of treatment discontinuation. Patients can participate in the study as many times as they want during the research period, which lasts until March 2028.

Outcome(s)

Primary Outcome

Patient
1. Change in monthly screening rates

Providers
2. The results of surveys regarding the feasibility and acceptability of the system

Secondary Outcome

Patients
1. Change in treatment cessation rates
2. Screening results
1) Scale on depression (PHQ-9)
2) Scale on anxiety (GAD-7)
3) Scale on posttraumatic stress symptoms (PCL-5)
4) Scale on adverse childhood experiences (ACE-J)
5) Scale on social determinants of health (PREPARE)
6) Background information, diagnosis, and treatment status

Providers
1. Background information
2. Job burnout

Key inclusion & exclusion criteria

• Age minimum: >= 18age old
• Age maximum: Not applicable
• Gender: Both

Include criteria

Patient
1. Patients who are under treatment in the endocrinology department of Tottori University Hospital

Provider
1. Medical providers working in the endocrinology department of Tottori University Hospital

Exclude criteria

Patient
1. Patients aged 18 years and above

Provider
1. None

Related Information

• Primary Sponsor: Hosoda-Urban Tamaki
• Source(s) of Monetary Support: Japan Society for the Promotion of Science